THIS ANNOUNCEMENT IS RESTRICTED AND IS NOT FOR PUBLICATION, RELEASE OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA,… read more →
The Venn Team have been busy in recent months attending conferences and seminars across Europe. Have you met them? If you would like to talk with our team email us… read more →
17 May 2018 Venn Life Sciences Holdings Plc (“Venn”, “Venn Life Sciences” or the “Company”) Preliminary Final Results for the year ended 31 December 2017 Venn Life Sciences (AIM: VENN),… read more →
The current issue of Biotech News & Life Sciences in the Netherlands features an article with our own Johan te Koppele discussing Venn’s end-to-end drug development capabilities in Breda and… read more →
Venn Life Sciences Holdings Plc (“Venn” or the “Company”) Trading and Strategy Update 15 February 2018 Venn Life Sciences (“Venn”) an Integrated Drug Development Partner offering a combination of drug… read more →